Recent developments in dynamic contrast-enhanced ultrasound imaging of tumor angiogenesis

Reshu Saini, Kenneth Hoyt

Research output: Contribution to journalReview article

25 Citations (Scopus)

Abstract

Angiogenesis is a critical process for tumor growth and metastatic dissemination. There is tremendous interest in the development of noninvasive methods for imaging tumor angiogenesis, and ultrasound (US) is an emerging platform technology to address this challenge. The introduction of intravascular microbubble contrast agents not only allows real-time visualization of tumor perfusion during an US examination, but they can be functionalized with specific ligands to permit molecular US imaging of angiogenic biomarkers that are overexpressed on the tumor endothelium. In this article, we will review current concepts and developing trends for US imaging of tumor angiogenesis, including relevant preclinical and clinical findings.

Original languageEnglish (US)
Pages (from-to)41-52
Number of pages12
JournalImaging in Medicine
Volume6
Issue number1
DOIs
StatePublished - Feb 1 2014

Fingerprint

Ultrasonography
Neoplasms
Microbubbles
Molecular Imaging
Contrast Media
Endothelium
Perfusion
Biomarkers
Ligands
Technology
Growth

Keywords

  • angiogenesis
  • contrast agent
  • microbubble
  • molecular imaging
  • ultrasound

ASJC Scopus subject areas

  • Radiological and Ultrasound Technology
  • Radiology Nuclear Medicine and imaging

Cite this

Recent developments in dynamic contrast-enhanced ultrasound imaging of tumor angiogenesis. / Saini, Reshu; Hoyt, Kenneth.

In: Imaging in Medicine, Vol. 6, No. 1, 01.02.2014, p. 41-52.

Research output: Contribution to journalReview article

@article{4d61818a873940539567389e9bad5f2f,
title = "Recent developments in dynamic contrast-enhanced ultrasound imaging of tumor angiogenesis",
abstract = "Angiogenesis is a critical process for tumor growth and metastatic dissemination. There is tremendous interest in the development of noninvasive methods for imaging tumor angiogenesis, and ultrasound (US) is an emerging platform technology to address this challenge. The introduction of intravascular microbubble contrast agents not only allows real-time visualization of tumor perfusion during an US examination, but they can be functionalized with specific ligands to permit molecular US imaging of angiogenic biomarkers that are overexpressed on the tumor endothelium. In this article, we will review current concepts and developing trends for US imaging of tumor angiogenesis, including relevant preclinical and clinical findings.",
keywords = "angiogenesis, contrast agent, microbubble, molecular imaging, ultrasound",
author = "Reshu Saini and Kenneth Hoyt",
year = "2014",
month = "2",
day = "1",
doi = "10.2217/iim.13.74",
language = "English (US)",
volume = "6",
pages = "41--52",
journal = "Imaging in Medicine",
issn = "1755-5191",
publisher = "Future Medicine Ltd.",
number = "1",

}

TY - JOUR

T1 - Recent developments in dynamic contrast-enhanced ultrasound imaging of tumor angiogenesis

AU - Saini, Reshu

AU - Hoyt, Kenneth

PY - 2014/2/1

Y1 - 2014/2/1

N2 - Angiogenesis is a critical process for tumor growth and metastatic dissemination. There is tremendous interest in the development of noninvasive methods for imaging tumor angiogenesis, and ultrasound (US) is an emerging platform technology to address this challenge. The introduction of intravascular microbubble contrast agents not only allows real-time visualization of tumor perfusion during an US examination, but they can be functionalized with specific ligands to permit molecular US imaging of angiogenic biomarkers that are overexpressed on the tumor endothelium. In this article, we will review current concepts and developing trends for US imaging of tumor angiogenesis, including relevant preclinical and clinical findings.

AB - Angiogenesis is a critical process for tumor growth and metastatic dissemination. There is tremendous interest in the development of noninvasive methods for imaging tumor angiogenesis, and ultrasound (US) is an emerging platform technology to address this challenge. The introduction of intravascular microbubble contrast agents not only allows real-time visualization of tumor perfusion during an US examination, but they can be functionalized with specific ligands to permit molecular US imaging of angiogenic biomarkers that are overexpressed on the tumor endothelium. In this article, we will review current concepts and developing trends for US imaging of tumor angiogenesis, including relevant preclinical and clinical findings.

KW - angiogenesis

KW - contrast agent

KW - microbubble

KW - molecular imaging

KW - ultrasound

UR - http://www.scopus.com/inward/record.url?scp=84896803630&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896803630&partnerID=8YFLogxK

U2 - 10.2217/iim.13.74

DO - 10.2217/iim.13.74

M3 - Review article

VL - 6

SP - 41

EP - 52

JO - Imaging in Medicine

JF - Imaging in Medicine

SN - 1755-5191

IS - 1

ER -